Showing 1 - 10 results of 10 for search 'Guochao Liao', query time: 0.04s
Refine Results
-
1
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives by Yuan Fang, Guochao Liao, Bin Yu
Published 2020-07-01
Article -
2
LSD1/KDM1A inhibitors in clinical trials: advances and prospects by Yuan Fang, Guochao Liao, Bin Yu
Published 2019-12-01
Article -
3
-
4
Preparation, Properties, and Applications of Graphene-Based Hydrogels by Guochao Liao, Junfeng Hu, Zhou Chen, Ruiqian Zhang, Guanchun Wang, Tairong Kuang
Published 2018-10-01
Article -
5
Natural products as LSD1 inhibitors for cancer therapy by Yuan Fang, Chao Yang, Zhiqiang Yu, Xiaochuan Li, Qingchun Mu, Guochao Liao, Bin Yu
Published 2021-03-01
Article -
6
-
7
-
8
Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from... by Deying Yang, Xiang Luo, Qinghai Lian, Lingqiang Gao, Chengxin Wang, Xiaoxiao Qi, Rong Zhang, Zhongqiu Liu, Guochao Liao
Published 2022-12-01
Article -
9
Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants by Liqing Chen, Xiaoxiao Qi, Dan Liang, Guiqi Li, Xiaofang Peng, Xiaohui Li, Bixia Ke, Huanying Zheng, Zhongqiu Liu, Changwen Ke, Guochao Liao, Liang Liu, Qian Feng
Published 2022-09-01
Article -
10
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants by Guochao Liao, Hungyan Lau, Zhongqiu Liu, Chinyu Li, Zeping Xu, Xiaoxiao Qi, Yu Zhang, Qian Feng, Runze Li, Xinyu Deng, Yebo Li, Qing Zhu, Sisi Zhu, Hua Zhou, Hudan Pan, Xingxing Fan, Yongchao Li, Dan Li, Liqing Chen, Bixia Ke, Zhe Cong, Qi Lv, Jiangning Liu, Dan Liang, An’an Li, Wenshan Hong, Linlin Bao, Feng Zhou, Hongbin Gao, Shi Liang, Bihong Huang, Miaoli Wu, Chuan Qin, Changwen Ke, Liang Liu
Published 2022-12-01
Article